Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/29/1998 | US5853724 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
12/29/1998 | US5853719 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
12/29/1998 | US5853718 Method of immunization using biologically contained bacterial cells |
12/29/1998 | US5853717 Methods and compositions of growth control for cells encapsulated within bioartificial organs |
12/29/1998 | US5853716 Genetically engineered chimeric viruses for the treatment of diseases associated with viral transactivators |
12/29/1998 | US5853702 Penicillium purpurogenum mutanases and nucleic acids encoding same |
12/29/1998 | US5853697 Methods of treating established colitis using antibodies against IL-12 |
12/29/1998 | US5853694 Transport vehicles for macromolecules |
12/29/1998 | CA2129554C Recombinant antibodies specific for tnf-.alpha. |
12/29/1998 | CA2096222C Bifunctional selectable fusion genes |
12/29/1998 | CA2084533C Process for lysing mycobacteria |
12/29/1998 | CA2053474C Plant transformation method using agrobacterium species adhered to microprojectiles |
12/29/1998 | CA2053473C Plant transformation method using agrobacterium species |
12/29/1998 | CA2038888C Secretion of hirudin derivatives |
12/29/1998 | CA1340296C Cell growth regulatory factor |
12/29/1998 | CA1340289C Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies |
12/29/1998 | CA1340288C Generation and selection of novel binding proteins |
12/26/1998 | CA2235778A1 Novel glmu |
12/24/1998 | DE19736198C1 Protease related protein |
12/24/1998 | DE19725371A1 Acceleration of optimisation of bio-polymers comprises improvement with set of single or double nucleic acid chains |
12/24/1998 | DE19725186A1 Herz- und Skelettmuskel-spezifische Nukleinsäure, ihre Herstellung und Verwendung Heart and skeletal muscle-specific nucleic acid, their preparation and use |
12/24/1998 | CA2234418A1 Human afc1 |
12/24/1998 | CA2234402A1 Human rce1 |
12/23/1998 | WO1998058086A2 Nucleic acid primers and probes for detecting hiv-1 and hiv-2 |
12/23/1998 | WO1998058085A1 High throughput screening for novel enzymes |
12/23/1998 | WO1998058084A1 High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers |
12/23/1998 | WO1998058083A2 Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
12/23/1998 | WO1998058080A1 A method for in vitro molecular evolution of protein function |
12/23/1998 | WO1998058069A1 Expression of fructose 1,6 bisphosphate aldolase in transgenic plants |
12/23/1998 | WO1998058068A2 A method for plant protection against insects or nematodes |
12/23/1998 | WO1998058067A1 A vector and method for preparation of dna libraries |
12/23/1998 | WO1998058066A1 New human lysophospholipase |
12/23/1998 | WO1998058065A1 Mold-resistant plants and method of construction of same |
12/23/1998 | WO1998058064A1 Kinesin-related protein |
12/23/1998 | WO1998058063A1 Polynucleotides encoding a growth factor-like protein (as amended) |
12/23/1998 | WO1998058062A1 Apo-2DcR |
12/23/1998 | WO1998058061A1 Mammalian genes; related reagents |
12/23/1998 | WO1998058060A1 Human app or a4ct sequences encoding the mutation 145f |
12/23/1998 | WO1998058059A1 Lag-3 splice variants |
12/23/1998 | WO1998058058A1 Hammerhead ribozymes with extended cleavage rule |
12/23/1998 | WO1998058057A1 Compositions inducing cleavage of rna motifs |
12/23/1998 | WO1998058055A2 Antisense nucleic acids targeting hbv |
12/23/1998 | WO1998058053A1 Human receptor tyrosine kinase, kdr |
12/23/1998 | WO1998058051A1 Transgenically produced prolactin |
12/23/1998 | WO1998057994A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
12/23/1998 | WO1998057991A1 Peptides and compounds that bind to the il-5 receptor |
12/23/1998 | WO1998057990A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity |
12/23/1998 | WO1998057989A1 Heregulin-like factor |
12/23/1998 | WO1998057987A2 Irs-p53h, human insulin receptor tyrosine kinase substrate |
12/23/1998 | WO1998057986A2 Human preprotachykinin b |
12/23/1998 | WO1998057984A2 Torsin, torsin genes, and methods of use |
12/23/1998 | WO1998057983A2 Mammalian neuro-growth factor like protein |
12/23/1998 | WO1998057982A2 Aib1, a steroid receptor co-activator |
12/23/1998 | WO1998057980A1 Peptides and compounds that bind to the il-5 receptor |
12/23/1998 | WO1998057976A1 Secreted proteins and polynucleotides encoding them |
12/23/1998 | WO1998057664A1 Interleukin converting enzyme (ice) and central nervous system damage |
12/23/1998 | WO1998057662A2 Therapeutic systems |
12/23/1998 | WO1998057658A1 Compact epstein-barr virus replicons |
12/23/1998 | WO1998057621A1 Angiogenic modulation by notch signal transduction |
12/23/1998 | WO1998057538A1 Complete activation of mammalian oocytes |
12/23/1998 | WO1998042830A3 Noey2 gene compositions and methods of use |
12/23/1998 | WO1998042741A3 Secreted proteins and polynucleotides encoding them |
12/23/1998 | WO1998041620A3 TRANSGENIC MICE CONTAINING A NUCLEIC ACID ENCODING TUMOR NECROSIS FACTOR-α UNDER THE CONTROL OF A CARDIAC SPECIFIC REGULATORY REGION |
12/23/1998 | WO1998039446A3 70 human secreted proteins |
12/23/1998 | EP0886142A1 Method for detecting anti-gadii antibody and method for diagnosing cancer using said detection method |
12/23/1998 | EP0885971A2 Methods and compositions for chromosome-specific staining |
12/23/1998 | EP0885967A2 Chaperone expression plasmids |
12/23/1998 | EP0885966A2 Novel compouds |
12/23/1998 | EP0885965A2 Histidine kinase polypeptides |
12/23/1998 | EP0885964A2 Method for cloning and producing the BssHII restriction endonuclease in E.coli |
12/23/1998 | EP0885963A2 Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide |
12/23/1998 | EP0885962A1 Microorganisms and process for the fermentative production of L-Cystein, L-Cystin, N-Acetyl-Serin or thiazolidin-derivates |
12/23/1998 | EP0885961A1 Novel insulin derivatives with rapid onset of action |
12/23/1998 | EP0885960A2 G-protein coupled receptor (H7TBA62) |
12/23/1998 | EP0885959A2 Human Wnt-5b protein |
12/23/1998 | EP0885958A1 Method for treating biopolymers, microorganisms or materials by using more than one type of magnetic particles |
12/23/1998 | EP0885956A1 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro) biological production of proteins |
12/23/1998 | EP0885903A2 Nucleic acid encoding streptococcus pheumoniae response regulator |
12/23/1998 | EP0885902A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
12/23/1998 | EP0885901A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
12/23/1998 | EP0885614A2 Method of ex vivo immunizing using heterologous intact bispecific and/or trispecific antibodies |
12/23/1998 | EP0885310A1 Genetic markers and methods for the detection of escherichia coli serotype-0157:h7 |
12/23/1998 | EP0885309A1 Direct molecular diagnosis of friedreich ataxia |
12/23/1998 | EP0885308A1 Compositions and methods of making embryonic stem cells |
12/23/1998 | EP0885307A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
12/23/1998 | EP0885306A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
12/23/1998 | EP0885305A1 Promoters from plant protoporphyrinogen oxidase genes |
12/23/1998 | EP0885304A2 Process for the production of degradation and/or conversion products of storage substances present in transgenic plant material with the help of a malting process |
12/23/1998 | EP0885303A1 Nucleic acid molecules coding for debranching enzymes from maize |
12/23/1998 | EP0885302A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
12/23/1998 | EP0885301A1 Down-regulation resistant c3 convertase |
12/23/1998 | EP0885300A1 Transferrin receptor genes of moraxella |
12/23/1998 | EP0885299A1 Wsx receptor and ligands |
12/23/1998 | EP0885298A1 Plastid transformation in arabidopsis thaliana |
12/23/1998 | EP0885297A1 Novel era |
12/23/1998 | EP0885296A1 An enzyme with galactanase activity |
12/23/1998 | EP0885293A1 Human chemokine polypeptides |
12/23/1998 | EP0885244A1 Peptide immunogens for vaccination against and treatment of allergy |
12/23/1998 | EP0885243A1 Crystal structure of apopain and uses thereof |
12/23/1998 | EP0885238A1 Substituted nucleic acid mimics |